Kliniske studier

Kliniske studier

Studie - kortnavnTittelStatus
PROMOEn fase II studie med pembrolizumab (MK-3475) for pasienter med osteosarkom som ikke er tilgjengelig for kurativ kirurgiPågående studie sammen med Italian Sarcoma Group 
A6181196A phase I/II study of Sunitinib in young patients with advanced gastrointestinal stromal tumorStengt. Ingen pasienter inkludert.
EurobossA European treatment protocol for bone sarcoma in patients older than 40 yearsStengt for inklusjon. Oppfølging pågår
SSG XX A Scandinavian Sarcoma group treatm.protocol for adult pas with non-met high-risk STS of extremities and trunk wall Stengt for inklusjon. Oppfølging pågår
STRASSA phase III randomised study of pre-operativ radiation plus surgery versus surgery alone for patients with retroperitoneal sarcomasStengt for inklusjon. Oppfølging pågår
SSG XXIIThree versus five years of adjuvant imatinib as treatment of patients with operable GIST with a high risk of reccurencePågående studie sammen med Skandinavia og Europeiske land
rEECurInternational Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma

Pågående studie sammen med Skandinavia og Europeiske land

 

EURAMOSA randomized trial of the European and American Osteosarcoma Study Group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy

Stengt for inklusjon.

Oppfølging pågår.

CREATECross-tumoral phase 2 clinical trial  exploring crizotinib (PF-02341066) in patients with advanced tumors induced by causal alterations of ALK and/or MET ("CREATE")Stengt for inklusjon. Oppfølging pågår.  
EpSSG NRSTS 2005A protocol for localized non-rhabdomyosarcom soft tissue sarcomaStengt for inklusjon.
EpSSG RMS 2005A protocol for non metastatic rhadomyosarcomaStengt for inklusjon.
ALT GISTA randomised phase II trial of imatinib alternating with regorafenib compared to imatinib treatment of advanced gastrointestinal stromal tumour (GIST)Stengt for inklusjon. Oppfølging pågår.
DOREMYDOse REduction of preoperative radiotherapy in MYxoid liposarcomasÅpen for inklusjon. Studie sammen med Nederland, England og skandinaviske land
SSG XVIIIShort (12 months) versus long (36 months) duration of adjuvant treatment with the tyrosine kinase inhibitor imantinib mesylate of operable GIST with a high risk for recurrence: A randomized phase III studyStengt for inklusjon. Oppfølging pågår.
SSG XIIIA Scandinavian Sarcoma Group treatment protocol for adult patients with high-risk STS of exstremities and trunk wallStengt for inklusjon. Oppfølging pågår.
MEMOSA mechanistic study of Mifamurtide (MTP-PE) in patients with metastatic and/or reccurent OsteosarcomaStengt for inklusjon. Ingen oppfølging
STOP-GISTDiscontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor that has become radiologically undetectable with treatmentÅpen for inklusjon. Studie sammen med andre sentre SSG sentre.  
NBTXR3A multicenter randomized, open-label phase II/III study, to compare the efficacy of NBTXR3, implanted as intratumor injection and activated by radiotherapy, versus radiotherapy alone in patients with locally advanced soft tissue sarcoma of the extremity and trunk wallStudien er stengt.
ARO-012A randomized, double-blind, placebo-controlled, multicenter, trial of Crenolanib in subjects with advanced or metastatic Gastrointestinal Stromal Tumor with a D842V mutation in the PDGFRA geneÅpen for inklusjon.
ISG/SSG IIIAn Italian-Scandinavian treatment protocol, non-metastatic Ewing`s family tumorsStengt for inklusjon. Oppfølging pågår.
SACROSAcral Chordoma: a Randomized & Observational study on surgery versus definitive radiation therapy in primary localized diseaseÅpnes i 2018
Fant du det du lette etter?
Tilbakemeldingen vil ikke bli besvart. Ikke send personlig informasjon, for eksempel epost, telefonnummer eller personnummer.